Eugene O. Major
Affiliations: | National Institutes of Health, Bethesda, MD |
Google:
"Eugene Major"Mean distance: 19.92 (cluster 6)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Barreras P, Pamies D, Monaco MC, et al. (2022) A human-derived 3D brain organoid model to study JC virus infection. Journal of Neurovirology |
| Li GH, Maric D, Major EO, et al. (2020) Productive HIV infection in astrocytes can be established via a nonclassical mechanism. Aids (London, England). 34: 963-978 |
| Eis PS, Bruno CD, Richmond TA, et al. (2020) Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy. Frontiers in Neurology. 11: 186 |
| Li GH, Maric D, Major EO, et al. (2020) Productive HIV infection in astrocytes can be established via a non-classical mechanism. Aids (London, England) |
| Ryerson LZ, Major EO. (2020) Natalizumab related progressive multifocal leukoencephalopathy Drug Discovery Today: Disease Models |
| Cortese I, Muranski P, Enose-Akahata Y, et al. (2019) Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy. The New England Journal of Medicine |
| Choi EH, Xu Y, Medynets M, et al. (2018) Activated T cells induce proliferation of oligodendrocyte progenitor cells via release of vascular endothelial cell growth factor-A. Glia. 66: 2503-2513 |
| McKenzie BA, Mamik MK, Saito LB, et al. (2018) Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America |
| Major EO, Yousry TA, Clifford DB. (2018) Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned. The Lancet. Neurology. 17: 467-480 |
| Soleimani-Meigooni DN, Schwetye KE, Angeles MR, et al. (2016) JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7. Journal of Neurovirology |